These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5138 related articles for article (PubMed ID: 59711)

  • 21. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
    Halliday WJ; Koppi TA; Khan JM; Davis NC
    J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-mediated immunity and specific serum factors in human cancer: the leukocyte adherence inhibition test.
    Maluish A; Halliday WJ
    J Natl Cancer Inst; 1974 May; 52(5):1415-20. PubMed ID: 4831432
    [No Abstract]   [Full Text] [Related]  

  • 23. Leucocyte adherence inhibition assay for cell-mediated immunity and immunodiagnosis of pancreatic cancer.
    Onji M
    Gastroenterol Jpn; 1984 Aug; 19(4):328-35. PubMed ID: 6333369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of the leukocyte migration inhibition assay to evaluate antigenic differences in human breast cancers and melanomas.
    Cannon B; McCoy JL; Connor RJ; Jerome L; Keys L; Dean HH; Herberman RB
    J Natl Cancer Inst; 1978 May; 60(5):969-78. PubMed ID: 76682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of sera from patients with breast cancer for blocking and induction of leukocyte adherence inhibition.
    Tanaka F; Sawada K; Yonemoto RH
    Gan; 1980 Oct; 71(5):589-95. PubMed ID: 7014342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Armed human monocytes challenged with a sensitizing cancer extract release substances pharmacologically similar to leukotrienes.
    Thomson DM; Phelan K; Morton DG; Bach MK
    Int J Cancer; 1982 Sep; 30(3):299-306. PubMed ID: 7129679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leukocyte adherence inhibition: an automated microassay demonstrating specific antigen recognition and blocking activity in two murine tumor systems.
    Leveson SH; Howell JH; Holyoke ED; Goldrosen MH
    J Immunol Methods; 1977; 17(1-2):153-62. PubMed ID: 71330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leukocyte migration inhibition by cancer patients' sera.
    Cochran AJ; Mackie RM; Ross CE; Ogg LJ; Jackson AM
    Int J Cancer; 1976 Sep; 18(3):274-81. PubMed ID: 1066319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An examination of the immunology of cancer patients.
    Cochran AJ; Mackie RM; Grant RM; Ross CE; Connell MD; Sandilands G; Whaley K; Hoyle DE; Jackson AM
    Int J Cancer; 1976 Sep; 18(3):298-309. PubMed ID: 783052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blocking of the response by human T-lymphocytes to extracts of autologous cancer by monoclonal antibody to Class-I major histocompatibility complex gene products in the leukocyte adherence inhibition assay.
    Shenouda G; Thomson DM
    Cancer Res; 1984 Jul; 44(7):2762-8. PubMed ID: 6609766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amplification of lymph node cell tube leukocyte adherence inhibition (LAI) reactivity by leukocyte adherence inhibition factor (LAIF).
    Harding MW; Yang TJ
    Cell Immunol; 1984 Aug; 87(1):206-16. PubMed ID: 6204773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The capillary tube leucocyte migration technique (LMT) as a method for detection of serum inhibiting activity of tumour-directed, cellular hypersensitivity in patients with renal carcinomas.
    Kjoer M
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Apr; 82(2):294-6. PubMed ID: 4528017
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunological mechanisms of tube leukocyte adherence inhibition.
    Thomson DM; Grosser N
    Cancer Res; 1979 Feb; 39(2 Pt 2):576-81. PubMed ID: 83912
    [No Abstract]   [Full Text] [Related]  

  • 34. Endogenous immune complex nephropathy associated with malignancy I. Studies on the nature and immunopathogenic significance of glomerular bound antigen and antibody, isolation and characterization of tumor specific antigen and antibody and circulating immune complexes.
    Ozawa T; Pluss R; Lacher J; Boedecker E; Guggenheim S; Hammond W; McIntosh R
    Q J Med; 1975 Oct; 44(176):523-41. PubMed ID: 53850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensitization to tumour-associated antigens in human breast carcinoma.
    Cochran AJ; Grant RM; Spilg WG; Mackie RM; Ross CE; Hoyle DE; Russell JM
    Int J Cancer; 1974 Jul; 14(1):19-25. PubMed ID: 4617707
    [No Abstract]   [Full Text] [Related]  

  • 36. Arming of normal leukocytes with sera from patients with adenocarcinoma of the prostate.
    Bhatti RA; Ablin RJ; Condoulis W; Guinan PD
    Cancer Res; 1979 Sep; 39(9):3328-31. PubMed ID: 476662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the LAI test in patients with benign and malignant breast diseases.
    Kovarík J; Lauerová L; Ninger E; Munzarová M; Feit J; Zemanová D; Wotke R
    Neoplasma; 1983; 30(2):163-7. PubMed ID: 6843721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunity to melanoma associated antigens detected by both leukocyte adherence inhibition and antibody dependent cellular cytotoxicity assays.
    Plain MJ; Whitehead RH; Jose DG
    Pathology; 1983 Apr; 15(2):177-82. PubMed ID: 6888965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leukocyte migration inhibition of tumor antigen and purified protein derivative reactivity in guinea pigs sensitized to line 10 hepatocarcinoma and BCG.
    McCoy JL; Brandhorst J; Hanna MG
    J Natl Cancer Inst; 1978 Mar; 60(3):693-9. PubMed ID: 75270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Capillary tube leukocyte adherence inhibition: an assay for cell-mediated immunity in cancer patients.
    Urist MM; Boddie AW; Holmes EC; Morton DL
    Int J Cancer; 1976 Mar; 17(3):338-41. PubMed ID: 1254356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 257.